Noven Pharmaceuticals News

Noven Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information.

Novartis Pharma AG, operating as a subsidiary of Novartis AG, is engaged in providing treatments for various diseases and disorders such as Alzheimer's, Epilepsy, Parkinson's, Schizophrenia, Attention-Deficit/Hyperactivity Disorder, and Migraine.

India's top drug regulatory agency violated laws and colluded with pharmaceutical companies to approve medicines without clinical trials, a parliamentary panel said in a report.

Basel, May 7, 2012 - Results of the largest Phase III study of acromegaly patients show the novel therapy pasireotide long-acting release , was significantly more effective at inducing full biochemical control compared to the current standard medical therapy, SandostatinR LARR .

A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel October 25, 2011.

Oxitec's chief scientist, Luke Alphey, seen here, discovered how to genetically engineer the bugs so that their progeny self-destruct in the wild.

Visa says its profit for the first three months of the year was up 30 percent from the year before.

Novartis AG , Europe 's largest drugmaker, said it will buy closely held Fougera Pharmaceuticals for $1.5 billion in a deal to gain generic skin medications.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Novartis AG 's experimental drug for smoker's cough helped patients in a late-stage trial, and was at least as good as a treatment sold by Boehringer Ingelheim GmbH and Pfizer ... (more)

Roche 's Avastin and Novartis AG 's Lucentis Equal for Treating Wet AMD - National Institutes of Health Study Basel, Switzerland, May 01, 2012 -- Novartis International AG / Recent publicly-funded CATT trial highlights serious safety concerns around unlicensed ocular bevacizumab use versus Lucentis .